(Q58862256)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Clara Nervi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

9

Saverio Minucci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Alessandra Insinga

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Silvia Monestiroli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Simona Ronzoni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Vania Gelmetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Francesco Marchesi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Andrea Viale

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Pier Giuseppe Pelicci

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

English

0 references

publication date

26 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

71-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619634%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm1160

6 January 2020

exact match

0 references

cites work

Histone deacetylases and cancer: causes and therapies

1 reference

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?

21 January 2018

1 reference

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

21 January 2018

1 reference

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

21 January 2018

1 reference

Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.

21 January 2018

1 reference

Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.

21 January 2018

1 reference

PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors

21 January 2018

1 reference

The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells

21 January 2018

1 reference

Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.

21 January 2018

1 reference

A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest.

21 January 2018

1 reference

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor

21 January 2018

1 reference

Impairment of p53 acetylation, stability and function by an oncogenic transcription factor

21 January 2018

1 reference

The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems

21 January 2018

1 reference

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

21 January 2018

1 reference

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARα expression

21 January 2018

1 reference

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations

21 January 2018

1 reference

Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia

21 January 2018

1 reference

Histone deacetylase inhibitors: from target to clinical trials

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

RNA interference targeting Fas protects mice from fulminant hepatitis

1 reference